title: Filamentation of Escherichia coli K12 elicited by some monomeric, dimeric and trimeric complexes of ruthenium in various oxidation states.
abstract: A number of ruthenium complexes were tested for their ability to induce filamentation in Escherichia coli. These included monomeric and dimeric complexes with ruthenium in the II or III oxidation states, as well as mixed-valence complexes with ruthenium in the (II,III) oxidation states. In general, dimeric mixed-valence Ru(II,III) complexes were the most active class of compound, although some complexes of this type were relatively inactive. These were pyrazine- or bipyridyl-bridged complexes which are known to involve strong metal-ligand interaction, which stabilizes the Ru(II) oxidation state. Some Ru(III) complexes were also significantly active in induction of filamentous growth in E. coli. One of these was [Ru(NH3)5Cl]Cl2, which did not inhibit electron transport, Mg2+-ATPase activity or DNA synthesis in E. coli, but like [Ru2(NH3)6Br3]Br2 X H2O was a potent inhibitor of respiration-driven calcium transport in the organism. Filament-inducing activity of the complex was reduced in the presence of NaCl, but not in the presence of added Ca2+, ethanol, calcium pantothenate, or E. coli 'division promoting extract'. This behaviour is also similar to that of [Ru2(NH3)6Br3]Br2 X H2O. It is suggested that both complexes may induce filamentation in E. coli by a common mechanism, which may involve interference with calcium metabolism, or a wall or membrane target, rather than interaction with DNA.
authors.forename: J F
authors.initials: JF
authors.lastname: Gibson
authors.forename: M N
authors.initials: MN
authors.lastname: Hughes
authors.forename: R K
authors.initials: RK
authors.lastname: Poole
authors.forename: J F
authors.initials: JF
authors.lastname: Rees
mesh_terms: D000251:Adenosine Triphosphatases / Q000378:metabolism; D000818:Animals; D017301:Ca(2+) Mg(2+)-ATPase; D002417:Cattle; D004247:DNA / Q000378:metabolism; D004926:Escherichia coli / Q000187:drug effects* / Q000254:growth & development / Q000378:metabolism; D066298:In Vitro Techniques; D010084:Oxidation-Reduction; D010101:Oxygen Consumption / Q000187:drug effects; D012428:Ruthenium / Q000378:metabolism / Q000494:pharmacology*; D017975:Ruthenium Compounds
chemical_list: D017975:Ruthenium Compounds; C039420:pentaamminechlororuthenium; D012428:Ruthenium; D004247:DNA; D000251:Adenosine Triphosphatases; D017301:Ca(2+) Mg(2+)-ATPase